Loading...
Successful treatment with apatinib for refractory recurrent malignant gliomas: a case series
Malignant glioma (MG) is a common and refractory primary tumor with a high recurrence rate. There is still a lack of effective therapy for recurrent MG (rMG). We present here two cases of refractory rMG treated using apatinib, which is a new highly selective inhibitor to VEGFR. Case 1, a 37-year-old...
Na minha lista:
| Udgivet i: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5317326/ https://ncbi.nlm.nih.gov/pubmed/28243119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S119129 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|